Structuring Clo Reinvestment Periods

Structuring CLO Reinvestment Periods

Designs CLO reinvestment criteria with portfolio quality tests, trading guidelines, and concentration limits.

When To Use

• Structuring or amending the reinvestment period for a new or refinanced CLO
• Defining portfolio quality tests (WARF, WAS, WAL, diversity score, minimum recovery rate)
• Drafting or reviewing trading guidelines that govern discretionary and credit-risk/credit-improved sales
• Setting concentration limits by obligor, industry, rating bucket, or asset type
• Evaluating manager flexibility versus investor protection trade-offs during reinvestment
• Comparing reinvestment criteria across a manager's CLO platform or against market benchmarks

Inputs To Gather

• Deal term sheet or indenture draft — reinvestment period length, non-call period, WAL test end date
• Target portfolio parameters — par amount, expected WARF, WAS, WAL, diversity score, recovery rate assumptions
• Rating agency methodology — Moody's, S&P, or Fitch CLO criteria in effect [VERIFY current version]
• Concentration limit schedule — maximum single obligor, industry (Moody's 33-industry or S&P classification), CCC bucket, second-lien/covenant-lite caps
• Trading flexibility provisions — discretionary sale baskets (percentage of principal balance), credit-risk and credit-improved definitions, reinvestment overcollateralization conditions
• Manager track record — historical turnover rates, default rates, par build/erosion across prior deals
• Market comparables — recent BSL CLO indentures from comparable managers for benchmarking

Workflow

1. Map the reinvestment timeline — Confirm reinvestment period start/end, non-call end, and any step-down or amortization trigger dates. Identify whether the deal includes a post-reinvestment trading period and its constraints.

2. Define portfolio quality tests — Specify each collateral quality test with its initial target and covenant level:

   • Maximum WARF (e.g., 2850)
   • Minimum WAS (e.g., 3.50%)
   • Maximum WAL (e.g., 7.5 years declining to 4.0 by stated maturity)
   • Minimum diversity score (e.g., 60)
   • Minimum weighted-average recovery rate (e.g., 44.5%)
   • Determine whether tests are measured at time of trade vs. time of settlement [VERIFY indenture convention]

3. Set concentration limits — Build the concentration schedule:

   • Single obligor cap (typically 1.5%–2.0% of par)
   • Industry concentration (Moody's 33-industry: max per industry, e.g., 10%–12%; aggregate top-3 cap) [VERIFY applicable industry classification]
   • CCC-rated exposure cap (typically 7.5% par; excess haircut in OC tests)
   • Second-lien, covenant-lite, DIP loan, and non-U.S. obligor sub-limits
   • Fixed-rate asset cap and related hedge requirements

4. Draft trading guidelines — Define permissible reinvestment trades:

   • Credit-risk sales — obligor downgraded below threshold or placed on watch-negative; no volume cap
   • Credit-improved sales — obligor upgraded or spread tightened beyond threshold; often subject to annual basket (e.g., 20% of portfolio)
   • Discretionary trades — subject to maintaining or improving all collateral quality tests post-trade
   • Specify reinvestment criteria: acquired asset must satisfy eligibility criteria and not cause any quality test breach

5. Calibrate OC and IC coverage tests — Confirm overcollateralization and interest coverage trigger levels for each tranche and how reinvestment is restricted upon a test breach (e.g., diversion of interest proceeds to senior notes).

6. Benchmark against comparables — Compare proposed criteria to 3–5 recent deals from the same manager and 3–5 deals from peer managers. Flag any terms meaningfully tighter or looser than market.

7. Stress-test flexibility — Model scenarios (spread compression, credit deterioration, high default wave) to assess whether the reinvestment criteria provide sufficient manager flexibility without excessive par erosion risk.

Output

Produce a CLO Reinvestment Period Structuring Report containing:

• Reinvestment timeline summary — key dates, non-call/reinvestment/WAL test schedule
• Collateral quality test matrix — each test, its target level, covenant level, measurement convention, and cure mechanism
• Concentration limit schedule — tabular format with limit type, threshold, and haircut/excess treatment in OC tests
• Trading guidelines summary — permitted trade types, volume baskets, post-trade compliance requirements
• OC/IC test levels — per-tranche trigger and default levels with reinvestment lockout mechanics
• Comparable deal benchmarking table — side-by-side comparison of key reinvestment terms
• Manager flexibility assessment — qualitative view of how constraining the proposed terms are relative to market, with specific call-outs for atypical provisions
• Risk flags — any terms that may draw rating agency or investor pushback

Quality Checks

• All collateral quality tests reference the correct rating agency methodology version [VERIFY]
• Concentration limits are internally consistent (sub-limits do not exceed parent limits; aggregate caps are coherent)
• Trading guidelines clearly distinguish credit-risk, credit-improved, and discretionary buckets with no overlap or gap
• OC/IC trigger levels are consistent with the capital structure and rating agency required subordination
• WAL test step-down schedule aligns with expected portfolio amortization profile
• Benchmarking uses deals from the same vintage (within 12 months) and comparable portfolio type (BSL vs. MM)
• No quality test is set at a level that would be immediately breached by the target portfolio
• All dollar and percentage thresholds are expressed on a consistent basis (par amount vs. aggregate principal balance)